Ark Invest’s ARK Innovation ETF (NYSE:ARKK) purchased a substantial 264,596 shares of Recursion Pharmaceuticals. The value of this trade, calculated from the closing price of $6.88, is approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results